Outset Medical Inc.
(OM)
undefined
undefined%
At close: undefined
1.13
2.19%
After-hours Dec 13, 2024, 06:56 PM EST
Company Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis.
It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.
The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015.
Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
Outset Medical Inc.
Country | United States |
IPO Date | Sep 15, 2020 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 480 |
CEO | Leslie L. Trigg |
Contact Details
Address: 3052 Orchard Drive San Jose, California United States | |
Website | https://www.outsetmedical.com |
Stock Details
Ticker Symbol | OM |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001484612 |
CUSIP Number | 690145107 |
ISIN Number | US6901451079 |
Employer ID | 20-0514392 |
SIC Code | 3845 |
Key Executives
Name | Position |
---|---|
Leslie L. Trigg | President, Chief Executive Officer & Chairman |
Nabeel Ahmed | Chief Financial Officer |
Dr. Michael Aragon M.D. | Chief Medical Officer |
James S. Mazzola | Head of Investor Relations |
John L. Brottem J.D. | General Counsel & Secretary |
Marc Nash | Senior Vice President of Operations and R&D |
Nicole Shannon | Director of Marketing Communications |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 18, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 18, 2024 | 4 | Filing |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | 10-Q | Quarterly Report |
Nov 06, 2024 | 8-K | Current Report |
Nov 04, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |